FDA approves Roche drug for non-small cell lung cancer
The U.S. Food and Drug Administration has approved Roche's Tecentriq as adjuvant treatment following surgery and platinum-based chemotherapy, for adults with Stage II-IIIA non-small cell lung cancer, as determined by an FDA-approved ...
Oct 18, 2021
0
3